Logo image of CHR-DB-B.CA

CHORUS AVIATION INC (CHR-DB-B.CA) Stock Fundamental Analysis

TSX:CHR-DB-B - Toronto Stock Exchange - CA17040TAE25 - Currency: CAD

100.99  -0.01 (-0.01%)

Fundamental Rating

3

Overall CHR-DB-B gets a fundamental rating of 3 out of 10. We evaluated CHR-DB-B against 9 industry peers in the Passenger Airlines industry. CHR-DB-B has only an average score on both its financial health and profitability. CHR-DB-B does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

CHR-DB-B had positive earnings in the past year.
In the past year CHR-DB-B had a positive cash flow from operations.
In multiple years CHR-DB-B reported negative net income over the last 5 years.
Each year in the past 5 years CHR-DB-B had a positive operating cash flow.
CHR-DB-B.CA Yearly Net Income VS EBIT VS OCF VS FCFCHR-DB-B.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

1.2 Ratios

With a Return On Assets value of -17.42%, CHR-DB-B is not doing good in the industry: 77.78% of the companies in the same industry are doing better.
The Return On Equity of CHR-DB-B (-47.80%) is worse than 66.67% of its industry peers.
The Return On Invested Capital of CHR-DB-B (6.29%) is better than 77.78% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CHR-DB-B is in line with the industry average of 5.51%.
The last Return On Invested Capital (6.29%) for CHR-DB-B is above the 3 year average (5.30%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -17.42%
ROE -47.8%
ROIC 6.29%
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
CHR-DB-B.CA Yearly ROA, ROE, ROICCHR-DB-B.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

1.3 Margins

The Operating Margin of CHR-DB-B (6.77%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of CHR-DB-B has declined.
The Gross Margin of CHR-DB-B (65.04%) is better than 77.78% of its industry peers.
CHR-DB-B's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 6.77%
PM (TTM) N/A
GM 65.04%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
CHR-DB-B.CA Yearly Profit, Operating, Gross MarginsCHR-DB-B.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CHR-DB-B is destroying value.
The number of shares outstanding for CHR-DB-B has been reduced compared to 1 year ago.
The number of shares outstanding for CHR-DB-B has been increased compared to 5 years ago.
The debt/assets ratio for CHR-DB-B has been reduced compared to a year ago.
CHR-DB-B.CA Yearly Shares OutstandingCHR-DB-B.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
CHR-DB-B.CA Yearly Total Debt VS Total AssetsCHR-DB-B.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 2.21 indicates that CHR-DB-B is not a great score, but indicates only limited risk for bankruptcy at the moment.
CHR-DB-B's Altman-Z score of 2.21 is amongst the best of the industry. CHR-DB-B outperforms 88.89% of its industry peers.
CHR-DB-B has a debt to FCF ratio of 3.86. This is a good value and a sign of high solvency as CHR-DB-B would need 3.86 years to pay back of all of its debts.
The Debt to FCF ratio of CHR-DB-B (3.86) is better than 77.78% of its industry peers.
A Debt/Equity ratio of 0.68 indicates that CHR-DB-B is somewhat dependend on debt financing.
CHR-DB-B's Debt to Equity ratio of 0.68 is fine compared to the rest of the industry. CHR-DB-B outperforms 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF 3.86
Altman-Z 2.21
ROIC/WACC0.75
WACC8.43%
CHR-DB-B.CA Yearly LT Debt VS Equity VS FCFCHR-DB-B.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B

2.3 Liquidity

CHR-DB-B has a Current Ratio of 1.22. This is a normal value and indicates that CHR-DB-B is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.22, CHR-DB-B is in line with its industry, outperforming 44.44% of the companies in the same industry.
A Quick Ratio of 0.71 indicates that CHR-DB-B may have some problems paying its short term obligations.
CHR-DB-B has a worse Quick ratio (0.71) than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 0.71
CHR-DB-B.CA Yearly Current Assets VS Current LiabilitesCHR-DB-B.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2

3. Growth

3.1 Past

The earnings per share for CHR-DB-B have decreased by -5.14% in the last year.
CHR-DB-B shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -19.03% yearly.
The Revenue for CHR-DB-B has decreased by -14.15% in the past year. This is quite bad
CHR-DB-B shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.56% yearly.
EPS 1Y (TTM)-5.14%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%35.71%
Revenue 1Y (TTM)-14.15%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-18.31%

3.2 Future

Based on estimates for the next years, CHR-DB-B will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.82% on average per year.
CHR-DB-B is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -2.83% yearly.
EPS Next Y62.27%
EPS Next 2Y16.29%
EPS Next 3Y8.82%
EPS Next 5YN/A
Revenue Next Year-2.5%
Revenue Next 2Y-2.46%
Revenue Next 3Y-2.83%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CHR-DB-B.CA Yearly Revenue VS EstimatesCHR-DB-B.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
CHR-DB-B.CA Yearly EPS VS EstimatesCHR-DB-B.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 60.84, CHR-DB-B can be considered very expensive at the moment.
Based on the Price/Earnings ratio, CHR-DB-B is valued a bit more expensive than the industry average as 66.67% of the companies are valued more cheaply.
CHR-DB-B's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.54.
CHR-DB-B is valuated quite expensively with a Price/Forward Earnings ratio of 49.46.
CHR-DB-B's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. CHR-DB-B is more expensive than 66.67% of the companies in the same industry.
CHR-DB-B's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 35.28.
Industry RankSector Rank
PE 60.84
Fwd PE 49.46
CHR-DB-B.CA Price Earnings VS Forward Price EarningsCHR-DB-B.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

CHR-DB-B's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. CHR-DB-B is more expensive than 77.78% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CHR-DB-B is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 24.06
EV/EBITDA 16.1
CHR-DB-B.CA Per share dataCHR-DB-B.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

CHR-DB-B's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.98
PEG (5Y)N/A
EPS Next 2Y16.29%
EPS Next 3Y8.82%

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.46%, CHR-DB-B has a reasonable but not impressive dividend return.
CHR-DB-B's Dividend Yield is a higher than the industry average which is at 2.74.
Compared to the average S&P500 Dividend Yield of 2.40, CHR-DB-B is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.46%

5.2 History

On average, the dividend of CHR-DB-B grows each year by 21.58%, which is quite nice.
CHR-DB-B does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)21.58%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

The earnings of CHR-DB-B are negative and hence is the payout ratio. CHR-DB-B will probably not be able to sustain this dividend level.
The dividend of CHR-DB-B is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP-7.29%
EPS Next 2Y16.29%
EPS Next 3Y8.82%
CHR-DB-B.CA Yearly Income VS Free CF VS DividendCHR-DB-B.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

CHORUS AVIATION INC

TSX:CHR-DB-B (8/6/2025, 7:00:00 PM)

100.99

-0.01 (-0.01%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)05-06 2025-05-06/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners2.5%
Inst Owner ChangeN/A
Ins Owners1.32%
Ins Owner ChangeN/A
Market Cap2.61B
Analysts78.18
Price Target133.9 (32.59%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.46%
Yearly Dividend0.98
Dividend Growth(5Y)21.58%
DP-7.29%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.69%
Min EPS beat(2)3.87%
Max EPS beat(2)25.51%
EPS beat(4)3
Avg EPS beat(4)39.29%
Min EPS beat(4)-80.2%
Max EPS beat(4)207.96%
EPS beat(8)4
Avg EPS beat(8)7.83%
EPS beat(12)5
Avg EPS beat(12)1.78%
EPS beat(16)7
Avg EPS beat(16)0.15%
Revenue beat(2)0
Avg Revenue beat(2)-3.86%
Min Revenue beat(2)-3.95%
Max Revenue beat(2)-3.78%
Revenue beat(4)0
Avg Revenue beat(4)-6.49%
Min Revenue beat(4)-10.27%
Max Revenue beat(4)-3.78%
Revenue beat(8)3
Avg Revenue beat(8)-1.85%
Revenue beat(12)5
Avg Revenue beat(12)-1.08%
Revenue beat(16)9
Avg Revenue beat(16)6.44%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)8.7%
EPS NY rev (1m)0%
EPS NY rev (3m)8.79%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.04%
Revenue NY rev (1m)-0.21%
Revenue NY rev (3m)-0.71%
Valuation
Industry RankSector Rank
PE 60.84
Fwd PE 49.46
P/S 1.87
P/FCF 24.06
P/OCF 17.47
P/B 5.06
P/tB 5.15
EV/EBITDA 16.1
EPS(TTM)1.66
EY1.64%
EPS(NY)2.04
Fwd EY2.02%
FCF(TTM)4.2
FCFY4.16%
OCF(TTM)5.78
OCFY5.72%
SpS53.95
BVpS19.97
TBVpS19.63
PEG (NY)0.98
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.42%
ROE -47.8%
ROCE 8.48%
ROIC 6.29%
ROICexc 6.74%
ROICexgc 6.8%
OM 6.77%
PM (TTM) N/A
GM 65.04%
FCFM 7.78%
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
ROICexc(3y)5.99%
ROICexc(5y)5.28%
ROICexgc(3y)6.05%
ROICexgc(5y)5.32%
ROCE(3y)7.14%
ROCE(5y)6.44%
ROICexcg growth 3Y33.52%
ROICexcg growth 5Y7.31%
ROICexc growth 3Y33.18%
ROICexc growth 5Y7.15%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
F-Score6
Asset Turnover0.98
Health
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF 3.86
Debt/EBITDA 1.9
Cap/Depr 45.9%
Cap/Sales 2.93%
Interest Coverage 1.46
Cash Conversion 81.41%
Profit Quality N/A
Current Ratio 1.22
Quick Ratio 0.71
Altman-Z 2.21
F-Score6
WACC8.43%
ROIC/WACC0.75
Cap/Depr(3y)31.44%
Cap/Depr(5y)62.49%
Cap/Sales(3y)3.58%
Cap/Sales(5y)12.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.14%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%35.71%
EPS Next Y62.27%
EPS Next 2Y16.29%
EPS Next 3Y8.82%
EPS Next 5YN/A
Revenue 1Y (TTM)-14.15%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-18.31%
Revenue Next Year-2.5%
Revenue Next 2Y-2.46%
Revenue Next 3Y-2.83%
Revenue Next 5YN/A
EBIT growth 1Y-59.15%
EBIT growth 3Y-9.64%
EBIT growth 5Y-14.31%
EBIT Next Year88.24%
EBIT Next 3Y15.21%
EBIT Next 5YN/A
FCF growth 1Y-55.84%
FCF growth 3Y24.37%
FCF growth 5YN/A
OCF growth 1Y-51.04%
OCF growth 3Y12.73%
OCF growth 5Y0.25%